Oral squamous cell carcinoma (OSCC) is the sixth most common malignancy worldwide (Jemal et al. 2009). It occurs at an annual incidence of approximately 263,000, with a mortality rate of approximately 128,000 per year, and is accompanied by a 5-year survival rate of less than 50% (Jemal et al. 2009) (Vormittag et al. 2009). Despite significant diagnostic and therapeutic advances, the prognosis of patients with OSCC has not improved in the past three decades (Jemal et al. 2009). A major prognostic factor is locoregional relapse, as its diagnosis worsens survival to less than 30% (González-García et al.
https://ift.tt/2qjCP6W
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου